pharmaceuticals

Valeant CEO cuts outlook for ‘distracted’ company, shares plunge

Valeant Pharmaceuticals International Inc slashed its 2016 forecasts on Tuesday, as its new chief executive said he would focus on rebuilding the reputation of a “distracted organization” with a debt-loaded balance sheet. The maker of toenail fungus cream Jublia and anti-depressant drug Wellbutrin, which has faced intense scrutiny for business and accounting practices, missed first-quarter profit estimates on weakness in its dermatology business.

More:
Valeant CEO cuts outlook for ‘distracted’ company, shares plunge

pharmaceuticals

Pentagon eyes proposal for M&A changes in ‘weeks’

By Andrea Shalal WASHINGTON (Reuters) – The Pentagon and other U.S. government agencies should complete a legislative proposal in coming weeks to let regulators block proposed mergers for national security reasons, instead of just antitrust concerns, a top official said on Tuesday. Defense Undersecretary Frank Kendall, who oversees arms weapons acquisitions and industrial base issues for the Pentagon, made the comments in an interview, after first …

Read the rest here:
Pentagon eyes proposal for M&A changes in ‘weeks’

pharmaceuticals

Turing Pharma seeks CEO to replace Shkreli, plans job cuts

Shkreli, 32, resigned as CEO on Friday, a day after his arrest on charges that he had engaged in a Ponzi-like scheme. On Monday, KaloBios Pharmaceuticals said Shkreli was “terminated” as CEO and had resigned from the board. Turing did not specify the number of job cuts in a statement.

Go here to read the rest: 
Turing Pharma seeks CEO to replace Shkreli, plans job cuts

pharmaceuticals

Alibaba names new head of anti-counterfeiting, IP unit

(Reuters) – Alibaba Group Holding Ltd appointed Matthew Bassiur as head global intellectual property enforcement to oversee the company's anti-counterfeiting and intellectual property rights protection efforts. The appointment comes days after the Chinese e-commerce giant avoided being named on a U.S. blacklist for sites hosting the sale of fake goods. Alibaba's Taobao Marketplace and Alibaba.com were both previously on the piracy blacklist, which highlights markets

Read more: 
Alibaba names new head of anti-counterfeiting, IP unit

pharmaceuticals

Oil prices hit eleven-year low as global supply balloons

By Catherine Ngai NEW YORK (Reuters) – Brent crude oil prices hit their lowest in more than 11 years on Monday, while U.S. crude flirted with seven-year lows on more signs that swelling global supply looked set to outpace tepid demand again next year. Global oil production is running close to record highs and, with more barrels poised to enter the market

Read the original:
Oil prices hit eleven-year low as global supply balloons

pharmaceuticals

BMW hit with $40 million U.S. penalty for safety lapses

U.S. auto safety regulators on Monday fined BMW $10 million, part of a $40 million civil settlement over the German automaker's safety lapses. The fine is the second paid by BMW since 2012 and…

See the original post:
BMW hit with $40 million U.S. penalty for safety lapses

pharmaceuticals

Ericsson signs patent deal with Apple, shares soar

Swedish mobile telecom gear maker Ericsson said it had signed a patent license deal with Apple Inc over technology that helps smartphones and tablets connect to mobile networks, sending its shares up much as 8 percent. The deal ends a year-long dispute with Apple, one of the biggest legal battles in mobile technology and Ericson said…

Originally posted here:
Ericsson signs patent deal with Apple, shares soar

pharmaceuticals

KaloBios fires Shkreli as CEO

(Reuters) – Drugmaker KaloBios Pharmaceuticals Inc said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for the issue of soaring prices for prescription medications, has already stepped down as CEO of private drugmaker Turing Pharmaceuticals Inc, in addition to resigning from KaloBios' board of directors. Shkreli was arrested last week for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital…

See original here: 
KaloBios fires Shkreli as CEO

pharmaceuticals

KaloBios fires Shkreli as CEO

(Reuters) – Drugmaker KaloBios Pharmaceuticals Inc said it fired Martin Shkreli as chief executive on Dec. 17, the day he was arrested on charges of a securities fraud. Shkreli, who has become the poster child for the issue of soaring prices for prescription medications, has already stepped down as CEO of private drugmaker Turing Pharmaceuticals Inc, in addition to resigning from KaloBios' board of directors. Shkreli was arrested last week for engaging in what U.S. prosecutors said was a Ponzi-like scheme at his former hedge fund MSMB Capital …

Read more here: 
KaloBios fires Shkreli as CEO

pharmaceuticals

Fed’s Lacker says four rate hikes in 2016 would be ‘gradual’

Federal Reserve forecasts pointing to four interest rate hikes in 2016 show what the U.S. central bank means when it says it anticipates raising rates at a “gradual pace,” Richmond Fed President Jeffrey Lacker said on Friday.

See the original post:
Fed’s Lacker says four rate hikes in 2016 would be ‘gradual’

Next Page »